acf/google-ad-placement

Never miss a trade again with the fastest news alerts in the world!
 This headline only article is a sample of real-time intelligence
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Benzinga Pro</a> traders use to win in the markets everyday.
 Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters?
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Join 10,000+ serious traders in the Benzinga Pro community!</a>

Biotech

News

General

Protara Therapeutics, Inc.&nbsp;(NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will host a conference call and live webcast

Protara Therapeutics To Host Conference Call And Webcast To Review New Interim Data From Phase 2 ADVANCED-2 Trial Of TARA-002 In Patients With NMIBC On December 5, 2024 At 8:30 a.m. ET - Protara Therapeutics (NASDAQ:TARA)

Benzinga Newsdesk

Protara Therapeutics

TARA

Protara Therapeutics To Host Conference Call And Webcast To Review New Interim Data From Phase 2 ADVANCED-2 Trial Of TARA-002 In Patients With NMIBC On December 5, 2024 At 8:30 a.m. ET

Comments